Partner
In the News
Ryan Majerus discusses U.S. restrictions on Chinese biotech investments with MLex
October 30, 2026
| MLexRyan Majerus comments on the proposed U.S. restrictions on investments in Chinese biotechnology.
Third-Party Coverage:
US pharma’s Chinese biotech deals face uncertainty under Treasury proposal
Explore King & Spalding
Capabilities
International Trade